TBD Pharmatech’s CEO, Dr. Andrus Tasa, will be attending the prestigious 17th Annual European Life Science CEO Forum in person on February 28-29 in Zurich, Switzerland! This forum is a prime opportunity for networking, knowledge exchange, and collaboration within the life sciences industry. If you’re attending the event, we encourage you to book an appointment with Andrus Tasa. We look forward to connecting with you and exploring potential partnerships, innovations, or simply exchange ideas and industry insights. Let’s make the most out of this invaluable opportunity for growth and advancement in the field of life sciences! Read more about the
During the scientific competition organized by Rakett69 Teadusstuudio, and the teams of Wolf Group, Akzo Nobel, TBD Pharmatech, and Eesti Energia, prominent players in the Estonian chemical industry, engaged in friendly competition on January 18, 2024. The studio buzzed with innovative ideas and experiments, providing valuable hands-on engineering workshops for all participants. On this occasion, the teams had to build the highest possible tower out of newspaper, deliver the space capsule safely to the ground, and fly the paper rocket as far as possible. Above all, the event highlighted the inspiring and enjoyable nature of tackling new challenges collaboratively with
TBD Pharmatech was proud to be a part of CPhI Barcelona 24-26 October 2023. This year was the busiest CPhI yet and the atmosphere on the show floor was inspirational. Over 52,000 passionate professionals from around the world gathered at CPhI to connect with 1,800+ exhibitors, face-to-face at the heart of pharma. Our team Andrus Tasa, Anneli Lainela, Tõnis Tasa, Andi Kipper, Ain Uustare, Indrek Tammeaid and Mai Mitt were inspired to network with the community and showcase TBD Pharmatech’s high quality API development and manufacturing services for small molecules. We’re excited about the prospect of further collaboration and engagement